EULAR recommendations for the management of Behçet disease.
about
Hughes-Stovin syndromeBiologics, colchicine, corticosteroids, immunosuppressants and interferon-alpha for Neuro-Behçet's SyndromeInterventions for the management of oral ulcers in Behçet's diseaseBiologics, colchicine, corticosteroids, immunosuppressants and interferon-alpha for Neuro-Behçet's SyndromeClinical Immunology Review Series: an approach to the patient with recurrent orogenital ulceration, including Behçet's syndromeBehcet's Disease: Is There Geographical Variation? A Review Far from the Silk RoadA Clinical Picture of the Visual Outcome in Adamantiades-Behçet's DiseaseMucocutaneous Involvement in Behçet's Disease: How Systemic Treatment Has Changed in the Last Decades and Future PerspectivesCardiac manifestations in Behcet's diseaseAdalimumab in the management of Behçet's diseaseNeuro-Behçet's disease in childhood: a focus on the neuro-ophthalmological featuresBehçet's disease in children, an overviewGastrointestinal Behçet's disease: a reviewThe immunogenetics of Behçet's disease: A comprehensive reviewConditions in subjects with rheumatic diseases: pulmonary manifestations of vasculitidesGastrointestinal aspects of vasculitides.Behçet's Uveitis.Behçet's Disease: an Insight from a Cardiologist's Point of View.Proinflammatory cytokines and C-reactive protein in uveitis associated with Behçet's diseaseOral ulcer activity in Behcet's disease: Poor medication adherence is an underestimated risk factorBiological treatments in Behçet's disease: beyond anti-TNF therapy.An update on the use of biologic therapies in the management of uveitis in Behçet's disease: a comprehensive review.Similarities and differences between Behçet's disease and Crohn's disease.Efficacy of tumour necrosis factor-α antagonists in aphthous ulceration: review of published individual patient data.Diagnosis and treatment of cerebral vasculitis.Pediatric vasculitis.Behcet's Syndrome.Intravascular immunity as a key to systemic vasculitis: a work in progress, gaining momentum.Association between sarcoidosis and Behçet disease in a young woman with symptoms mimicking myasthaenia gravisThe value of glucocorticoid co-therapy in different rheumatic diseases--positive and adverse effectsRelationships of HLA-B51 or B5 genotype with Behcet's disease clinical characteristics: systematic review and meta-analyses of observational studies.Haemostatic Parameters in Patients with Behçet's DiseaseAcute myocardial infarction and subclavian artery occlusion in a 41-year-old woman with Behçet's disease: coronary and large vessel arteritisTreatment of neuro-Behçet's disease: an update.New Evidence-Based Treatment Approach in Behçet's Disease.Thrombosis in vasculitis: from pathogenesis to treatment.Cerebral Venous Thrombosis in the Mediterranean Area in Adults. Role of Behçet's Disease as an Underlying Cause.New insights in the clinical understanding of Behçet's disease.Neuro-Behçet's disease mimicking a cranial tumour.Outcome measures used in clinical trials for Behçet syndrome: a systematic review.
P2860
Q21202875-8C4EA0F3-50FC-427A-BE99-89FB62DD9A57Q24187204-9711A63F-A90C-48ED-90F5-E22DE5E95D73Q24193450-9CD85987-864E-4771-B5E7-985A131B7C4AQ24198961-DFFCC81B-B3F0-45B1-AC3F-DFDCC44D2363Q24654208-99F3F4A0-875F-4E22-8493-0B8DE0DE2054Q26770008-754BD45C-B62F-4B24-B64C-39B86D5E499CQ26777598-0337F1C7-56BD-409D-A97B-DBE5AB66EF88Q26799767-E993CDE6-A03D-4DEA-9BE6-5E8CB606681AQ26829983-A685026F-C45F-4184-A28D-9920EEC2FFC5Q26861428-34F6976F-EFE6-4EF6-A6BD-3316F9FBC507Q27000669-B7C9488A-034B-4243-9E6A-D174D4862E2DQ28069448-A3B47014-B0CF-450D-AEF5-7986C6D22D04Q28084556-6F052740-1505-4E20-9A76-69F73328DCB5Q28088324-6B30F4E8-430C-4C72-8D0D-3E790227AE79Q28393792-45184748-30F5-43A9-A6D9-872B65359E7AQ30240787-226A74B8-3900-46D9-BACD-CB79C6453253Q33559788-A9446D7F-26F2-42C7-AD65-7D0206C47B80Q33760174-09014F45-82AC-4135-AB66-CE694DD75755Q33796694-E847996D-7F4A-4478-8E56-78363B379B63Q33806649-62882EFB-B720-44BA-BD92-7730E770450AQ33908217-CED63A9A-6750-4C11-B64D-8172A2E1E53AQ33910781-89E7B774-B827-49E8-B90B-86C585E96BF0Q34048005-3F899074-8D4D-4AB6-A390-6B4CA5662414Q34142185-9084C27B-9AEE-4E3C-A972-134C107C4DDAQ34156332-AF8AA2C3-38A6-46E3-BFC6-2FA89DEF1268Q34245925-E8890FE4-CB74-4B7D-A400-7D9C670FAB18Q34311953-45A69FD3-7284-4468-9D6A-36F91C1139C7Q34377832-A18A0290-C41D-4E23-BFFD-00348C39897AQ34535671-A66C36E9-9F67-4684-9811-35EECA8B2F31Q34597321-8854E05C-8BD9-4A30-8840-AC3F2917055FQ34635091-6C724F1C-E482-445C-A781-40D4C00E970BQ34661678-FF1564DF-E8E8-4180-B341-FA6A4DA848BBQ34952398-BECF24AA-B916-4B17-A775-6090B96A21C0Q34974052-74767640-D8AB-46C2-9B4A-094962A813E3Q35295186-35558C2E-3997-4A25-B667-E926D070994AQ35440601-629E9835-DE27-4293-AAAA-D91B07485983Q35560256-929C8434-8424-484E-965D-F047A70673C3Q35648227-A971DE7A-3588-4B8F-8AF5-69C28C7E2B94Q35779279-F81CAE54-DEAF-43CB-9ED3-31D18F568727Q35868282-EFE8C4B5-6C1C-43C8-8082-2FF07F4A96DB
P2860
EULAR recommendations for the management of Behçet disease.
description
2008 nî lūn-bûn
@nan
2008 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
EULAR recommendations for the management of Behçet disease.
@ast
EULAR recommendations for the management of Behçet disease.
@en
EULAR recommendations for the management of Behçet disease.
@nl
type
label
EULAR recommendations for the management of Behçet disease.
@ast
EULAR recommendations for the management of Behçet disease.
@en
EULAR recommendations for the management of Behçet disease.
@nl
prefLabel
EULAR recommendations for the management of Behçet disease.
@ast
EULAR recommendations for the management of Behçet disease.
@en
EULAR recommendations for the management of Behçet disease.
@nl
P2093
P50
P356
P1476
EULAR recommendations for the management of Behçet disease.
@en
P2093
A M Chamberlain
EULAR Expert Committee
I Olivieri
M H Houman
P304
P356
10.1136/ARD.2007.080432
P407
P577
2008-01-31T00:00:00Z